Role of Isoflavones in the Hypocholesterolemic Effect of Soy
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Epidemiologic data suggest an inverse relationship between the consumption of soy isoflavones and cardiovascular disease risk. The aims of this review are to determine if isoflavones play a role in the hypocholesterolemic effect of soy and whether the studies realized with that scope were adequately designed. In humans, most studies have been performed in postmenopausal women. The results are inconsistent, however; some studies show a decrease in total cholesterol and low-density lipoprotein concentrations, and an increase in high-density lipoprotein levels, and other investigations fail to show any beneficial effect of soy isoflavones on lipid profiles. In most studies, beneficial effects could not be attributed with certainty to soy isoflavones. If these components have any health-protecting effect in humans, it is small in comparison with the effect of soy protein itself. There are currently not enough data to recommend the consumption of isoflavone supplements to lower plasma cholesterol levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids
Anderson, J. W., Johnstone, B. M., & Cook-Newell, M. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330502 · Cited by 2,048
Cited by
The pros and cons of phytoestrogens
Patisaul, H. B., & Jefferson, W. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.03.003 · Cited by 746
“Intriguingly, removal of the isoflavones from the soy protein does not eliminate the modest impact on LDL levels, suggesting that the soy protein itself, rather than the isoflavones, is producing the modest benefit [56].”
Soy, Soy Foods and Their Role in Vegetarian Diets
Rizzo, G., & Baroni, L. (2018) · Nutrients · doi:10.3390/nu10010043 · Cited by 498
Soybean Foods and Their Benefits: Potential Mechanisms of Action
Omoni, A. O., & Aluko, R. E. (2005) · Nutrition Reviews · doi:10.1111/j.1753-4887.2005.tb00141.x · Cited by 294
Hypocholesterolaemic effects of milk-kefir and soyamilk-kefir in cholesterol-fed hamsters
Liu, J.-R., Wang, S.-Y., Chen, M.-J., Chen, H.-L., Yueh, P.-Y., & Lin, C.-W. (2006) · British Journal of Nutrition · doi:10.1079/bjn20061752 · Cited by 115
“Many nutritional and medical investigations have revealed the great potential of soya protein in lowering serum cholesterol level (Carroll & Kurowska, 1995; Demonty et al. 2003; Ascencio et al. 2004).”
A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women
Wu, A. H., Stanczyk, F. Z., Martinez, C., Tseng, C.-C., Hendrich, S., Murphy, P., Chaikittisilpa, S., Stram, D. O., & Pike, M. C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.5.1133 · Cited by 47
“Moreover, the amount of soy we added (15 g soy protein) was lower than the 25 g approved by the US Food and Drug Administration for its cholesterol-lowering action and substantially lower than the amount of soy used in most other clinical trials (50).”
Background
Metadata
- Authors
- Demonty, I., Lamarche, B., & Jones, P. J. H.
- Venue
- Nutrition Reviews
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-06-01
- Volume
- 61
- Issue
- 6
- Pages
- 189-203
- ISSN
- 0029-6643 (ISSN-L)
- 1753-4887
- OpenAlex
- W2053513438
- Cited by
- 67
- References
- 1
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.